MyoKardia (MYOK) PT Raised to $48 at Wells Fargo
Tweet Send to a Friend
Wells Fargo raised its price target on MyoKardia (NASDAQ: MYOK) to $48.00 (from $31.00) while maintaining a Outperform rating.Analyst Jim ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
